CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

HSBC Adjusts Price Target on Gilead Sciences to $175 From $155, Keeps Buy Rating

Positive
AI Analysis

Summary

HSBC raised its price target on Gilead Sciences from $155 to $175 while maintaining a Buy rating on the stock.

Importance:2/10
Sentiment:
0.40
price_target_increaseanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on September 10, 2026 10:09 AM

Read Original